Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in Regenerative Medicine dealmaking
2.1. Introduction
2.2. Regenerative Medicine partnering over the years
2.3. Most active Regenerative Medicine dealmakers
2.4. Regenerative Medicine partnering by deal type
2.5. Regenerative Medicine partnering by therapy area
2.6. Deal terms for Regenerative Medicine partnering
2.6.1 Regenerative Medicine partnering headline values
2.6.2 Regenerative Medicine deal upfront payments7
2.6.3 Regenerative Medicine deal milestone payments
2.6.4 Regenerative Medicine royalty rates
Chapter 3 – Leading Regenerative Medicine deals
3.1. Introduction
3.2. Top Regenerative Medicine deals by value
Chapter 4 – Most active Regenerative Medicine dealmakers
4.1. Introduction
4.2. Most active Regenerative Medicine dealmakers
4.3. Most active Regenerative Medicine partnering company profiles
Chapter 5 – Regenerative Medicine contracts dealmaking directory
5.1. Introduction
5.2. Regenerative Medicine contracts dealmaking directory
Chapter 6 – Regenerative Medicine dealmaking by technology type
Chapter 7 – Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking
Appendices
Appendix 1 – Regenerative Medicine deals by company A-Z
Appendix 2 – Regenerative Medicine deals by stage of development
Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation
Appendix 3 – Regenerative Medicine deals by deal type
Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty
Appendix 4 – Regenerative Medicine deals by therapy area
Appendix 5 –Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering
Table of figures
Figure 1: Regenerative Medicine partnering since 2012
Figure 2: Active Regenerative Medicine dealmaking activity– 2012 to 2018
Figure 3: Regenerative Medicine partnering by deal type since 2012
Figure 4: Regenerative Medicine partnering by disease type since 2012
Figure 5: Regenerative Medicine deals with a headline value
Figure 6: Regenerative Medicine deals with an upfront value
Figure 7: Regenerative Medicine deals with a milestone value
Figure 8: Regenerative Medicine deals with a royalty rate value
Figure 9: Top Regenerative Medicine deals by value since 2012
Figure 10: Most active Regenerative Medicine dealmakers 2012 to 2018
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events